VNDA
VANDA PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
VANDA PHARMACEUTICALS INC (VNDA) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$37.59M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 2 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders51 also report options
Congress trades0
Price$5.17vs quarter-end-15.52%
Sectors0
This quarter's moves
Top holderNew0
Added3
Trimmed / sold3
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $437.0K— of portfolio71,4002026 Q2
Value $126.7K— of portfolio20,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $437.0K | — | — |
| Ken GriffinPUT | $126.7K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.